Assessment of Effectiveness of Continuous Non-invasive Haemodynamic Monitor by Compared to Invasive Blood Pressure and Pulse Oximeter Monitoring on Patients Undergoing General Anesthesia Surgeries for More Than 60 Minutes
Assessment of the Effectiveness of the Continuous Non-invasive Haemodynamic Monitor
1 other identifier
observational
55
0 countries
N/A
Brief Summary
The goal of this observational study is to assess whether the continuous non-invasive haemodynamic monitor MOH200 (measuring blood pressure as well as pulse rate) is effective or not in people undergoing general anesthetic surgeries for more than 60 minutes with planned invasive blood pressure and pulse oximeter monitoring. Researchers will compare blood pressure data derived from MOH200 to the invasive blood pressure (IBP) data to see if the MOH200 is effective to measure the blood pressure of a surgical person. Also, researchers will compare pulse rate data drived from MOH200 to that from the pulse oximeter to see if the MOH200 is effective to measure the pulse rate of a surgical person. Participants will be asked to be applied with MOH200 monitoring while IBP monitoring and pulse oximeter are applied. And after 30 minutes of the surgery, researchers will monitor the adverse effects occurred on the skin of participants to assess the safety of MOH200.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2024
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 22, 2024
CompletedFirst Posted
Study publicly available on registry
April 25, 2024
CompletedStudy Start
First participant enrolled
June 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedApril 25, 2024
April 1, 2024
7 months
April 22, 2024
April 22, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
Continuous Non -invasive Blood Pressure Measurement from MOH200
The blood pressure is measured by MOH200 and recorded on the CRF for every 5 minutes, including mean blood pressure, diastolic blood pressure and systolic blood pressure.
During the surgery
Invasive Blood Pressure Measurement from Arterial Line
The blood pressure is synchronously measured by the radial arterial line and also recorded on the CRF for every 5 minutes, including mean arterial pressure, diastolic blood pressure and systolic blood pressure.
During the surgery
Pulse Rate Measurement from MOH200
The pulse rate is measured by the MOH200 and recorded on the CRF for every 5 minutes.
During the surgery
Pulse Rate Measurement from Pulse Oximeter
The pulse rate is measured by the pulse oximeter and recorded on the CRF for every 5 minutes during the surgery.
During the surgery
Secondary Outcomes (1)
The Occurrence of Pressure Pores
Once after all the subjects are recruited and the clinical trials are finished
Eligibility Criteria
Patients are going to undergoing a general anesthetic surgery for more than 60 minutes at the site (Tongji Hospital, Tongji Medical College of HUST) who are accord with the inclusion criteria and do not satisfy the exclusion criteria.
You may qualify if:
- Patients undergoing general anesthesia surgeries for more than 60 minutes with IBP monitoring
- Patients aging between 4 to 80 years old (including at least 5 pediatric subjects between 4 to 12 years old, and as for subjects over 12 years old, up to 60% of subjects between 12 to 50 years old, at least 15% of subjects between 50 to 60 years old, at least 15% of subjects between 60 to 70 years old, and at least 10% of subjects over 70 years old)
- At least 30% of subjects is male and 30% is female
- Volunteer to participate the study and sign the informed consent form willingly
You may not qualify if:
- Patients with severe heart diseases which affect the stability of haemodynamics
- Patients applied with the heart-lung machine, defibrillator or cardiopulmonary bypass
- Patients with coagulation disorders, vasculopathy or vascular prostheses
- Patients with cutaneous diseases, infections or trauma of the measured part of the body leading to failure of data acquisition
- Patients with mental diseases, epilepsy or other diseases leading to involuntrary movements of the body
- Patients with BMI no more than 17 or no less than 30 kg/m\^2
- Patients who are pregnant or at the unstable stage of diseases or with severe shock
- Patients with infections or trauma at the position of artery cannulation, whose pulse is untouchable or who get positive in the Allen's test
- Patients with diseases that the investigators think unsuitable for participating the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Zhiqiang Zhou
Department of Anesthesiology, Tongji Hospital, Tongji Medical College of HUST
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 22, 2024
First Posted
April 25, 2024
Study Start
June 1, 2024
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
April 25, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share